Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

• Prif Awduron: Shin Takayama (Awdur), Takao Namiki (Awdur), Ryutaro Arita (Awdur), Rie Ono (Awdur), Akiko Kikuchi (Awdur), Minoru Ohsawa (Awdur), Natsumi Saito (Awdur), Satoko Suzuki (Awdur), Hajime Nakae (Awdur), Seiichi Kobayashi (Awdur), Tetsuhiro Yoshino (Awdur), Tomoaki Ishigami (Awdur), Koichiro Tanaka (Awdur), Kotaro Nochioka (Awdur), Airi Takagi (Awdur), Masaru Mimura (Awdur), Takuhiro Yamaguchi (Awdur), Tadashi Ishii (Awdur), Akito Hisanaga (Awdur), Kazuo Mitani (Awdur), Takashi Ito (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

The traditional Japanese (Kampo) medicine, kakkonto with shosaikotokakikyosekko, has antiviral and anti-inflammatory effects. In this randomized trial, patients with mild and moderate coronavirus disease (COVID-19) were randomly allocated to the control group receiving conventional treatment for sym...